Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Lung Cancer

Free Subscription 31.08.2020 1 Am J Respir Crit Care Med 1 Am J Surg 10 Ann Thorac Surg 5 BMC Cancer 1 Cancer Cell 1 Cancer Epidemiol Biomarkers Prev 1 Cancer Lett 2 Cancer Res 1 Carcinogenesis 2 Chest 1 Clin Cancer Res 2 Clin Lung Cancer 1 Eur J Cancer 2 Eur J Cardiothorac Surg 1 Eur Respir J 3 J Cancer Res Clin Oncol 9 J Thorac Cardiovasc Surg 5 J Thorac Oncol 5 Lung Cancer 1 N Engl J Med 1 Oncogene 5 Oncol Rep 1 PLoS Biol 5 PLoS One 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Respir Crit Care Med

1. PEIKERT T, Bartholmai BJ, Maldonado F
   Radiomics-based Management of Indeterminate Lung Nodules? Are We There Yet?
   Am J Respir Crit Care Med. 2020;202:165-167.
   PubMed        
   
   

   
   Am J Surg

2. HASSON RM, Fay KA, Phillips JD, Millington TM, et al
   Rural barriers to early lung cancer detection: Exploring access to lung cancer screening programs in New Hampshire and Vermont.
   Am J Surg. 2020 Jul 25. pii: S0002-9610(20)30383.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

3. FRIEDBERG JS, Simone CB 2nd, Culligan MJ, Putt ME, et al
   Posterior Intercostal Lymph Nodes Double Recurrence and Death Risk in Malignant Pleural Mesothelioma.
   Ann Thorac Surg. 2020;110:241-250.
   PubMed         Abstract available
   
   
4. MARIOLO AV, Seguin-Givelet A, Gossot D
   Fatal Stroke After Reoperation for Lobar Torsion.
   Ann Thorac Surg. 2020;110:e51-e53.
   PubMed         Abstract available
   
   
5. FEDERSPIEL CK, Kelsen J, Fugleholm K
   Delayed Iatrogenic Intracranial Hypotension After Thoracotomy.
   Ann Thorac Surg. 2020;110:e35-e37.
   PubMed         Abstract available
   
   
6. FUKUTOMI T, Yoshizu A, Matsuda K, Okamoto H, et al
   Bronchial Sleeve Resection and Double-Barreled Reconstruction for a Carcinoid Tumor.
   Ann Thorac Surg. 2020;110:e67-e69.
   PubMed         Abstract available
   
   
7. PERKINS SL, Krajancich B, Yang CJ, Hargreaves BA, et al
   A Patient-Specific Mixed-Reality Visualization Tool for Thoracic Surgical Planning.
   Ann Thorac Surg. 2020;110:290-295.
   PubMed         Abstract available
   
   
8. GERACI TC, Ferrari-Light D, Wang S, Mitzman B, et al
   Robotic Sleeve Resection of the Airway: Outcomes and Technical Conduct Using Video Vignettes.
   Ann Thorac Surg. 2020;110:236-240.
   PubMed         Abstract available
   
   
9. CHEN X, Jin R, Xiang J, Han D, et al
   Methods for Dissecting Intersegmental Planes in Segmentectomy: A Randomized Controlled Trial.
   Ann Thorac Surg. 2020;110:258-264.
   PubMed         Abstract available
   
   
10. PLOENES T, Schildhaus HU, Theegarten D, Stehling F, et al
    Pleuropulmonary Blastoma Misinterpreted as Spontaneous Pneumothorax in an Infant.
    Ann Thorac Surg. 2020;110:e79.
    PubMed        
    
    
11. ZHANG Y, Chen H
    Ground glass opacity predominant lung cancer is independently associated with node negative status.
    Ann Thorac Surg. 2020 Aug 21. pii: S0003-4975(20)31335.
    PubMed        
    
    
12. UDELSMAN BV, Madariaga ML, Chang DC, Kozower BD, et al
    Concordance of Clinical and Pathological Nodal Staging in Resectable Lung Cancer.
    Ann Thorac Surg. 2020 Aug 24. pii: S0003-4975(20)31355.
    PubMed         Abstract available
    
    

    
    BMC Cancer

13. LI X, Zhang W, Yu Y, Zhang G, et al
    CT features and quantitative analysis of subsolid nodule lung adenocarcinoma for pathological classification prediction.
    BMC Cancer. 2020;20:60.
    PubMed         Abstract available
    
    
14. FOWLER H, Belot A, Ellis L, Maringe C, et al
    Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers.
    BMC Cancer. 2020;20:2.
    PubMed         Abstract available
    
    
15. NAGHIBZADEH-TAHAMI A, Marzban M, Yazdi-Feyzabadi V, Dabiri S, et al
    Is opium use associated with an increased risk of lung cancer? A case-control study.
    BMC Cancer. 2020;20:807.
    PubMed         Abstract available
    
    
16. LI J, Zheng Q, Zhao X, Zhao J, et al
    Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis.
    BMC Cancer. 2020;20:793.
    PubMed         Abstract available
    
    
17. LV Z, Lei T
    Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters.
    BMC Cancer. 2020;20:56.
    PubMed         Abstract available
    
    

    
    Cancer Cell

18. DEVARAKONDA S, Govindan R, Morgensztern D
    Mastering the Complex Targeted Therapy for Non-small Cell Lung Cancer.
    Cancer Cell. 2020 Aug 10. pii: S1535-6108(20)30372.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

19. LIM RJ, Liu B, Krysan K, Dubinett SM, et al
    Lung Cancer and Immunity Markers.
    Cancer Epidemiol Biomarkers Prev. 2020 Aug 20. pii: 1055-9965.EPI-20-0716.
    PubMed         Abstract available
    
    

    
    Cancer Lett

20. SHOU J, You L, Yao J, Xie J, et al
    Corrigendum to "Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3" [Canc Lett 379 (2016) 124-133].
    Cancer Lett. 2020;493:13-15.
    PubMed        
    
    

    
    Cancer Res

21. MARQUES M, Tranchant R, Risa-Ebri B, Suarez-Solis ML, et al
    Combined MEK and PI3K/p110beta Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features.
    Cancer Res. 2020;80:843-856.
    PubMed         Abstract available
    
    
22. JING B, Wang T, Sun B, Xu J, et al
    IL6/STAT3 Signaling Orchestrates Premetastatic Niche Formation and Immunosuppressive Traits in Lung.
    Cancer Res. 2020;80:784-797.
    PubMed         Abstract available
    
    

    
    Carcinogenesis

23. IZZOTTI A, Balansky R, Micale RT, Pulliero A, et al
    Modulation of smoke-induced DNA and microRNA alterations in mouse lung by licofelone, a triple COX-1, COX-2 and 5-LOX inhibitor.
    Carcinogenesis. 2020;41:91-99.
    PubMed         Abstract available
    
    

    
    Chest

24. GIERADA DS, Pinsky PF
    Survival After Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial.
    Chest. 2020 Aug 18. pii: S0012-3692(20)34234.
    PubMed         Abstract available
    
    
25. SINGHVI D, Bon J
    Computed Tomography Imaging and Comorbidities in Chronic Obstructive Pulmonary Disease: Beyond Lung Cancer Screening.
    Chest. 2020 Aug 21. pii: S0012-3692(20)34274.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

26. GERBER DE, Putnam WC, Fattah FJ, Kernstine KH, et al
    Concentration-dependent early anti-vascular and anti-tumor effects of itraconazole in non-small cell lung cancer.
    Clin Cancer Res. 2020 Aug 26. pii: 1078-0432.CCR-20-1916.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

27. DARWIN A, Rose T, Tandon A, Tanvetyanon T, et al
    Development of Bronchopleural Fistula After Durvalumab Consolidation for Stage III Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2020 Jul 30. pii: S1525-7304(20)30232.
    PubMed        
    
    
28. CHEN XR, Hou X, Li DL, Sai K, et al
    Management of Non-Small-Cell Lung Cancer Patients Initially Diagnosed With 1 to 3 Synchronous Brain-Only Metastases: A Retrospective Study.
    Clin Lung Cancer. 2020 Jul 30. pii: S1525-7304(20)30233.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

29. BANG YJ, Golan T, Dahan L, Fu S, et al
    Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ).
    Eur J Cancer. 2020;137:272-284.
    PubMed         Abstract available
    
    

    
    Eur J Cardiothorac Surg

30. GONFIOTTI A, Gatteschi L, Salvicchi A, Bongiolatti S, et al
    Clinical courses and outcomes of five patients with primary lung cancer surgically treated while affected by Severe acute respiratory syndrome coronavirus 2.
    Eur J Cardiothorac Surg. 2020;58:598-604.
    PubMed         Abstract available
    
    
31. FIORELLI S, Massullo D, Ibrahim M, Piccioni F, et al
    Perspectives in surgical and anaesthetic management of lung cancer in the era of coronavirus disease 2019 (COVID-19).
    Eur J Cardiothorac Surg. 2020 Aug 26. pii: 5897205. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Eur Respir J

32. LEGENDRE M, Butt A, Borie R, Debray MP, et al
    Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer.
    Eur Respir J. 2020 Aug 27. pii: 13993003.02806-2020.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

33. MA X, Wang S, Zhang Y, Wei H, et al
    Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC).
    J Cancer Res Clin Oncol. 2020 Aug 27. pii: 10.1007/s00432-020-03362.
    PubMed         Abstract available
    
    
34. ZHOU L, Zhang M, Li R, Xue J, et al
    Pseudoprogression and hyperprogression in lung cancer: a comprehensive review of literature.
    J Cancer Res Clin Oncol. 2020 Aug 28. pii: 10.1007/s00432-020-03360.
    PubMed         Abstract available
    
    
35. DU TQ, Li X, Zhong WS, Tian JD, et al
    Brain metastases of lung cancer: comparison of survival outcomes among whole brain radiotherapy, whole brain radiotherapy with consecutive boost, and simultaneous integrated boost.
    J Cancer Res Clin Oncol. 2020 Aug 26. pii: 10.1007/s00432-020-03359.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

36. MORI M, Geirsson A
    Reply from authors: Identifying lessons that could be generalized across different disease burdens.
    J Thorac Cardiovasc Surg. 2020;160:e133-e134.
    PubMed        
    
    
37. SONG KJ, Flores RM
    REPLY: ROBOTIC-ASSISTED SEGMENTECTOMY: DOING IT SIMPLY BECAUSE WE CAN?
    J Thorac Cardiovasc Surg. 2020;160:e176.
    PubMed        
    
    
38. LAZZARO R, Patton B
    Commentary: Maximum surgery through minimal incisions.
    J Thorac Cardiovasc Surg. 2020;160:849-850.
    PubMed        
    
    
39. MADARIAGA ML, Gaissert HA
    Reply from authors: The many benefits of a multidisciplinary evaluation of lung nodules.
    J Thorac Cardiovasc Surg. 2020;160:e177-e178.
    PubMed        
    
    
40. LIN J
    Commentary: Mind the gap: Adherence to quality measures for stage I/II non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jun 26. pii: S0022-5223(20)31753.
    PubMed        
    
    
41. ZHANG Y, Chen X, Li H
    Robotic or thoracoscopic segmentectomy: Each complements the other.
    J Thorac Cardiovasc Surg. 2020;160:e175.
    PubMed        
    
    
42. RAKOVICH G, Bujold A
    The "multispecialty clinic": Toward a new paradigm in thoracic oncology?
    J Thorac Cardiovasc Surg. 2020;160:e176-e177.
    PubMed        
    
    
43. VEERAMACHANENI NK
    Commentary: Minimally invasive sleeve lobectomy-from case report curiosity to standard of care?
    J Thorac Cardiovasc Surg. 2020;160:852-853.
    PubMed        
    
    
44. CERFOLIO RJ
    Commentary: Why so many sleeve resections and pneumonectomies and why the nonabsorbable suture?
    J Thorac Cardiovasc Surg. 2020;160:847-848.
    PubMed        
    
    

    
    J Thorac Oncol

45. AHN MJ
    Molecular Testing in Lung Cancer: Still Big Gap in Implementation for Real-World Use.
    J Thorac Oncol. 2020;15:1399-1400.
    PubMed        
    
    
46. IKEDA S, Kato T, Kenmotsu H, Ogura T, et al
    A phase II study of atezolizumab for pretreated non-small cell lung cancer with idiopathic interstitial pneumonias.
    J Thorac Oncol. 2020 Aug 25. pii: S1556-0864(20)30678.
    PubMed         Abstract available
    
    
47. GEDVILAITE V, Danila E, Cicenas S, Smailyte G, et al
    Lung Cancer in Lithuania.
    J Thorac Oncol. 2020;15:1401-1405.
    PubMed        
    
    
48. PASQUINELLI MM, Tammemagi MC, Kovitz KL, Durham ML, et al
    Risk Prediction Model versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria - Reducing Race Disparities.
    J Thorac Oncol. 2020 Aug 17. pii: S1556-0864(20)30638.
    PubMed         Abstract available
    
    
49. BRAUN M, Fuchs V, Kian W, Roisman L, et al
    Nivolumab Induced Hepatocanalicular Cholestasis and Liver Rejection in a Patient With Lung Cancer and Liver Transplant.
    J Thorac Oncol. 2020;15:e149-e150.
    PubMed        
    
    

    
    Lung Cancer

50. MADISON R, Schrock AB, Castellanos E, Gregg JP, et al
    Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling.
    Lung Cancer. 2020;148:69-78.
    PubMed         Abstract available
    
    
51. WADDLE MR, Ko SJ, May J, Kaleem T, et al
    Improving identification of candidates for lung cancer screening in a high risk population.
    Lung Cancer. 2020;148:79-85.
    PubMed         Abstract available
    
    
52. THAI AA, Stuart E, Te Marvelde L, Milne RL, et al
    Reply to the letter-to-the editor "Hospital volume and the case for centralisation of surgical services".
    Lung Cancer. 2020;142:140-141.
    PubMed        
    
    
53. HANDRA-LUCA A
    C-Myc in mucinous colloid carcinoma of the lung.
    Lung Cancer. 2020;143:93-94.
    PubMed        
    
    
54. STIRLING R, Stenger M, Zalcberg J
    Comment on: 'Hospital lung surgery volume and patient outcomes'.
    Lung Cancer. 2020;142:138-139.
    PubMed        
    
    

    
    N Engl J Med

55. DRILON A, Oxnard GR, Tan DSW, Loong HHF, et al
    Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer.
    N Engl J Med. 2020;383:813-824.
    PubMed         Abstract available
    
    

    
    Oncogene

56. ZHANG X, Li F, Tang Y, Ren Q, et al
    miR-21a in exosomes from Lewis lung carcinoma cells accelerates tumor growth through targeting PDCD4 to enhance expansion of myeloid-derived suppressor cells.
    Oncogene. 2020 Aug 27. pii: 10.1038/s41388-020-01406.
    PubMed         Abstract available
    
    

    
    Oncol Rep

57. WANG H, Kanmangne D, Li R, Qian Z, et al
    miR30a3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2.
    Oncol Rep. 2020;43:646-654.
    PubMed         Abstract available
    
    
58. LI Y, Yin Y, Ma J, Sun Y, et al
    Combination of AAVmediated NUPR1 knockdown and trifluoperazine induces premature senescence in human lung adenocarcinoma A549 cells in nude mice.
    Oncol Rep. 2020;43:681-688.
    PubMed         Abstract available
    
    
59. CAO PP, Chen WJ, Pang HL, Shen WW, et al
    Effect of CUL4A on the metastatic potential of lung adenocarcinoma to the bone.
    Oncol Rep. 2020;43:662-670.
    PubMed         Abstract available
    
    
60. HU F, Li C, Zheng X, Zhang H, et al
    Lung adenocarcinoma resistance to therapy with EGFRtyrosine kinase inhibitors is related to increased expression of cancer stem cell markers SOX2, OCT4 and NANOG.
    Oncol Rep. 2020;43:727-735.
    PubMed         Abstract available
    
    
61. ZHAO C, Zheng S, Yan Z, Deng Z, et al
    CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
    Oncol Rep. 2019 Dec 11. doi: 10.3892/or.2019.7426.
    PubMed         Abstract available
    
    

    
    PLoS Biol

62. XIAO GY, Schmid SL
    FCHSD2 controls oncogenic ERK1/2 signaling outcome by regulating endocytic trafficking.
    PLoS Biol. 2020;18:e3000778.
    PubMed         Abstract available
    
    

    
    PLoS One

63. KIM MS, Kim SH, Yang SH, Kim MS, et al
    Restricting extracellular Ca2+ on gefitinib-resistant non-small cell lung cancer cells reverses altered epidermal growth factor-mediated Ca2+ response, which consequently enhances gefitinib sensitivity.
    PLoS One. 2020;15:e0238155.
    PubMed         Abstract available
    
    
64. REMON J, Swalduz A, Planchard D, Ortiz-Cuaran S, et al
    Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay.
    PLoS One. 2020;15:e0234302.
    PubMed         Abstract available
    
    
65. SANTOS-SANCHEZ V, Cordoba-Dona JA, Viciana F, Escolar-Pujolar A, et al
    Geographical variations in cancer mortality and social inequalities in southern Spain (Andalusia). 2002-2013.
    PLoS One. 2020;15:e0233397.
    PubMed         Abstract available
    
    
66. FU L, Wang H, Wei D, Wang B, et al
    The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
    PLoS One. 2020;15:e0233283.
    PubMed         Abstract available
    
    
67. CHEN JL, Wu JN, Lv XD, Yang QC, et al
    The value of red blood cell distribution width, neutrophil-to-lymphocyte ratio, and hemoglobin-to-red blood cell distribution width ratio in the progression of non-small cell lung cancer.
    PLoS One. 2020;15:e0237947.
    PubMed         Abstract available
    
    

    
    Thorax

68. HORSFALL LJ, Burgess S, Hall I, Nazareth I, et al
    Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank.
    Thorax. 2020 Aug 27. pii: thoraxjnl-2020-214756.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: